ANEBULO PHARMACEUTICALS INC ANEB
COM · Common Stock · CUSIP 034569103
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersLakeway, TX
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 25.9m as of 2024-05-06, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $2.73.
Trends to Q2 2024
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 12 |
| Q4 2022 | 13 |
| Q1 2023 | 11 |
| Q2 2023 | 13 |
| Q3 2023 | 13 |
| Q4 2023 | 15 |
| Q1 2024 | 16 |
| Q2 2024 | 14 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 2 | 4 |
| Q1 2023 | 4 | 4 |
| Q2 2023 | 5 | 3 |
| Q3 2023 | 5 | 2 |
| Q4 2023 | 8 | 5 |
| Q1 2024 | 7 | 8 |
| Q2 2024 | 6 | 6 |
Biggest buyers
| Nantahala Capital Management, LLC | Added | +511.1k |
| GEODE CAPITAL MANAGEMENT, LLC | Added | +28.5k |
| VANGUARD GROUP INC | Added | +401 |
| BANK OF AMERICA CORP /DE/ | New | +65 |
| ROYAL BANK OF CANADA | Added | +13 |
| JPMORGAN CHASE & CO | Added | +2 |
Biggest sellers
| MORGAN STANLEY | Reduced | -798.4k |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -25.3k |
| Tower Research Capital LLC (TRC) | Reduced | -1.8k |
| BlackRock Inc. | Reduced | -288 |
| UBS Group AG | Sold out | -144 |
| WELLS FARGO & COMPANY/MN | Sold out | -62 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| English Aron R. 13D · may seek influence no change · filed 2025-02-27 | 51.1% |
| Nantahala Capital Management, LLC 13G · institution -0.1 pts · filed 2026-02-13 | 8.5% |
| MANGROVE PARTNERS IM, LLC 13G · institution new · filed 2025-03-17 | 6.2% |
Insider purchases and sales in Q2 2024
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2024.
Holders, Q2 2024
| Manager | Shares | Change |
|---|---|---|
| 22NW, LP 12.50% of their portfolio | 5.4m $14.6m | Unchanged |
| Nantahala Capital Management, LLC 0.14% of their portfolio | 1.0m $2.8m | Added +511.1k |
| LVW Advisors, LLC 0.26% of their portfolio | 642.0k $1.8m | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 399.2k $1.1m | Reduced -798.4k |
| Ikarian Capital, LLC 0.13% of their portfolio | 157.9k $431.0k | Unchanged |
| VANGUARD GROUP INC 0.00% of their portfolio | 153.9k $420.1k | Added +401 |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 51.3k $140.1k | Added +28.5k |
| BOOTHBAY FUND MANAGEMENT, LLC 0.00% of their portfolio | 19.0k $51.8k | Unchanged |
| BlackRock Inc. 0.00% of their portfolio | 3.8k $10.3k | Reduced -288 |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 3.3k $9.0k | Reduced -1.8k |
| BANK OF AMERICA CORP /DE/ 0.00% of their portfolio | 65 $177 | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 51 $0 | Added +13 |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 20 $54 | Added +2 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |